Findings from the company's third annual AI Report suggest that a collaborative approach is needed to boost confidence in AI  Key highlights AI adoption surges: 85% of Canadians and 89% of Americans use AI, demonstrating widespread embrace of the technology Transparency and safety matter: More than three-quarters of respondents want companies to review AI for harms before new tools are released, and provide easy-to-understand explanations Calls for inclusion and respect: About 7-in-10 respondents want companies to ask for and listen to customer input on how AI is deployed Near-universal call for robust governance: 90% of respondents in both countries want AI regulated, with clear expectations for accountability and oversight TORONTO, Jan. 28, 2026 /PRNewswire/ - 'Include our feedback as you build AI' is the key message from American and Canadian respondents polled in TELUS' latest cross-border study, AI Trust Atlas: Public perspectives on bridging the AI trust gap . With 85% of Canadians and 89% of Americans reporting that they are using AI, familiarity with the technology is growing – and so are calls for inclusion and engagement in how AI is designed and deployed.

VANCOUVER, BC, Jan. 16, 2026 /PRNewswire/ - TELUS Corporation ("TELUS" or the "Company") today confirmed the successful completion of the full redemption of its outstanding C$600 million 3.75% Notes, Series CV due March 10, 2026 (CUSIP No. 87971MBC6), as initially announced on December 16, 2025.

“Canadians are not happy with the quality of service they're getting at the moment, and Telus cutting jobs is not going to help.” - Michael Phillips, USW

TELUS Health's global scale and accelerating commercial momentum present compelling partnership opportunity VANCOUVER, BC, Jan. 8, 2026 /PRNewswire/ - TELUS Corporation ("TELUS") (TSX: T) (NYSE: TU) today announced it has engaged TD Securities Inc. and Jefferies Securities, Inc. as financial advisors to assist with strategy and timeline for the monetisation of its TELUS Health business, which may include the identification and evaluation of potential strategic partnerships, including evaluation of all partnership structures. TELUS Health has reached a pivotal inflection point – it is an asset of consequence, serving more than 160 million lives across its global footprint of over 200 countries and territories, while generating year-to-date operating revenue, EBITDA and cash flow of $1.5 billion, $258 million and $99 million, respectively, as of the third quarter of 2025.

VANCOUVER, BC, Jan. 5, 2026 /PRNewswire/ - TELUS Corporation ("TELUS" or the "Company") today announced that several members of its board of directors and its executive leadership team, including Darren Entwistle, President and CEO of TELUS, through the course of November and December have acquired a total of 357,090 additional TELUS shares in the open market, reflecting their confidence in TELUS' compelling value proposition and long-term growth prospects. Collectively, senior officers of TELUS' executive leadership team and board of directors hold a total of approximately 2.4 million TELUS common shares as of December 31, 2025.

Shares of TELUS Corporation (NYSE: TU - Get Free Report) (TSE: T) have earned a consensus recommendation of "Moderate Buy" from the twelve ratings firms that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation, five have given a buy recommendation and one

VANCOUVER, British Columbia--(BUSINESS WIRE)--TELUS Digital named a Leader in NelsonHall's 2025 NEAT report for CX transformation, recognized for AI innovation and end-to-end digital capabilities.

Base shelf prospectus is accessible, and prospectus supplement will be accessible for CAD$ offering within two business days, through SEDAR+ VANCOUVER, BC , Dec. 4, 2025 /PRNewswire/ - TELUS announced today it has priced an offering of US$1.5 billion aggregate principal amount of Fixed-to-Fixed Rate Junior Subordinated Notes in two series (together, the "US Notes").  The US$800 million Fixed-to-Fixed Rate Junior Subordinated Notes, Series C due June 9, 2056 will initially bear interest at an annual rate of 6.375% and reset every five years starting on June 9, 2031 at an annual rate equal to the Five-Year U.S. Treasury rate plus a spread of 2.694%, provided that the interest rate during any five-year interest period will not reset below 6.375%.

VANCOUVER, BC , Dec. 4, 2025 /PRNewswire/ - TELUS Corporation ("TELUS" or the "Company") today announced the commencement of separate offers (the "Offers") to purchase for cash up to C$500,000,000 (the "Maximum Purchase Amount") in aggregate purchase price, excluding accrued and unpaid interest, of its outstanding notes of the seven series listed in the table below (collectively, the "Notes"), which Maximum Purchase Amount may be increased, decreased or waived by the Company in its sole discretion. Each Offer is subject to the satisfaction or waiver of certain conditions, including the Financing Condition (as defined below) The Offers The Offers are made upon the terms and subject to the conditions set forth in the Offer to Purchase dated December 4, 2025, relating to the Notes (the "Offer to Purchase").

TELUS advances plan to step down Discounted DRIP in 2026  TELUS pauses dividend growth until share price reflects growth prospects VANCOUVER, BC , Dec. 3, 2025 /PRNewswire/ - TELUS Corporation ("TELUS" or the "Company") today provided an updated mid-term outlook and further details of its enhanced capital allocation framework, including a new multi-year free cash flow growth target. In addition, TELUS will systematically step down its Discounted DRIP beginning in early 2026 and pause its dividend growth while continuing to pay its quarterly dividend at the most recent level of $0.4184 per share.